Israeli scientists are conducting clinical trials to develop and perfect an inhaler that will deliver medical cannabis concentrates for patients suffering from asthma and cancer.
According to the Regina Leader Post, patients with asthma, lung diseases, and other respiratory issues may prefer to inhale medical marijuana rather than smoke it. The same goes for patients seeking relief from the pain of cancer or the unpleasant side effects of cancer treatment.
The Israeli researchers are conducting clinical trials for a specially made inhaler that offers metered doses of cannabis. Rafa Pharmaceuticals along with Panaxia Pharmaceuticals are collaborating to ensure that the inhalers can deliver the correct amount of herb to the patients flawlessly.
“The clinical trial is performed as part of the registration procedure for new products which we are about to launch in Israel this year in collaboration with Rafa,” Panaxia CEO said in a statement to PR Newswire. “Through access to cannabis